Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Qvist

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 12, 2007
Osteoclasts prefer aged boneK Henriksen, D J Leeming, I Byrjalsen, et al.
Journal of Clinical Pharmacology|July 28, 2010
Lessons learned from the development of oral calcitonin: the first tablet formulation of a protein in phase III clinical trialsM A Karsdal, K Henriksen, A C Bay-Jensen, et al.
Clinical Biochemistry|August 17, 2010
Enzyme-linked immunosorbent serum assays (ELISAs) for rat and human N-terminal pro-peptide of collagen type I (PINP)--assessment of corresponding epitopesD J Leeming, D V Larsen, C Zhang, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|October 13, 2011
A novel marker for assessment of liver matrix remodeling: an enzyme-linked immunosorbent assay (ELISA) detecting a MMP generated type I collagen neo-epitope (C1M)Dj Leeming, Y He, Ss Veidal, et al.
International Journal of Epidemiology|October 30, 2016
Cohort Profile: The Prospective Epidemiological Risk Factor (PERF) studyJ S Neergaard, K Dragsbæk, S N Kehlet, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|April 29, 2009
Biochemical markers and the FDA Critical Path: how biomarkers may contribute to the understanding of pathophysiology and provide unique and necessary tools for drug developmentM A Karsdal, K Henriksen, D J Leeming, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 12, 2007
Osteoclasts prefer aged boneK Henriksen, D J Leeming, I Byrjalsen, et al.
Journal of Clinical Pharmacology|July 28, 2010
Lessons learned from the development of oral calcitonin: the first tablet formulation of a protein in phase III clinical trialsM A Karsdal, K Henriksen, A C Bay-Jensen, et al.
Clinical Biochemistry|August 17, 2010
Enzyme-linked immunosorbent serum assays (ELISAs) for rat and human N-terminal pro-peptide of collagen type I (PINP)--assessment of corresponding epitopesD J Leeming, D V Larsen, C Zhang, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|October 13, 2011
A novel marker for assessment of liver matrix remodeling: an enzyme-linked immunosorbent assay (ELISA) detecting a MMP generated type I collagen neo-epitope (C1M)Dj Leeming, Y He, Ss Veidal, et al.
International Journal of Epidemiology|October 30, 2016
Cohort Profile: The Prospective Epidemiological Risk Factor (PERF) studyJ S Neergaard, K Dragsbæk, S N Kehlet, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|April 29, 2009
Biochemical markers and the FDA Critical Path: how biomarkers may contribute to the understanding of pathophysiology and provide unique and necessary tools for drug developmentM A Karsdal, K Henriksen, D J Leeming, et al.
Pageof 6